Poxel Announces Multiple TWYMEEG (Imeglimin) Abstracts Accepted for Oral Presentation
Nine Imeglimin abstracts to be presented at the 66th Annual Meeting of the Japanese Diabetes Society Regulatory News: POXEL SA (Euronext: POXEL FR0012432516) (Paris:POXEL), a clinical stage